Extensive Expertise in Endocrinology: Adrenal crisis in assisted reproduction and pregnancy DOI Creative Commons
Ulla Feldt‐Rasmussen

European Journal of Endocrinology, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

Abstract Appropriate management of adrenal insufficiency in pregnancy is challenging due to the rarity both primary, secondary and tertiary forms disease as well lack evidence-based recommendations guide clinicians glucocorticoid sometimes also mineralocorticoid dosage adjustments. Debut during requires immediate diagnosis it can lead crisis, intrauterine growth restriction foetal demise. Diagnosis difficult overlap symptoms its crisis with those pregnancy. Adrenal stable replacement treatment needs careful monitoring adapt physiological changes requirement hormones. This hampered because diagnostic threshold most adrenocortical hormones not applicable The frequent use assisted reproduction technology controlled ovarian hyperstimulation these patient groups induced low fertility has created an unrecognised risk crises accelerated oestrogen stimulation increased even be life-threatening complications for woman foetus. area consensus between gynaecologists endocrinologists referral centres alleviate such gestational risk. Patient partner education, EU emergency card contribute better outcomes. There a strong need more research on e.g. improvement treatment, biomarkers optimisation this field, which suffers from rare nature diseases poor funding.

Язык: Английский

Congenital adrenal hyperplasia DOI
Matthias K. Auer, Anna Nordenström, Svetlana Lajić

и другие.

The Lancet, Год журнала: 2022, Номер 401(10372), С. 227 - 244

Опубликована: Дек. 8, 2022

Язык: Английский

Процитировано

97

Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance DOI Creative Commons
Talat Mushtaq, Salma Ali, Nabil Boulos

и другие.

Archives of Disease in Childhood, Год журнала: 2023, Номер 108(11), С. 871 - 878

Опубликована: Апрель 12, 2023

Adrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal glands. This can be a primary disorder or secondary to adrenocorticotropic hormone deficiency suppression exogenous glucocorticoids. Symptoms AI in children may initially non-specific and include growth faltering, lethargy, poor feeding, weight loss, abdominal pain, vomiting lingering illnesses. treated with replacement doses hydrocortisone. At times physiological stress such as illness, trauma surgery, there an increased requirement for glucocorticoids, which if untreated lead crisis death. There are no unified guidelines those <18 years old UK, leading substantial variation management AI. paper sets out guidance intercurrent medical, dental surgical procedures allow timely appropriate recognition treatment young people.

Язык: Английский

Процитировано

17

3D printed, personalized sustained release cortisol for patients with adrenal insufficiency DOI Creative Commons
Sejad Ayyoubi, Eveline E. M. van Kampen, L.I. Kocabas

и другие.

International Journal of Pharmaceutics, Год журнала: 2022, Номер 630, С. 122466 - 122466

Опубликована: Дек. 6, 2022

The standard of care for patients with Adrenal Insufficiency (AI) is suboptimal. Administration hydrocortisone three times a day produces plasma cortisol fluctuations associated negative health outcomes. Furthermore, there high inter-individual variability in need, necessitating personalized approach. It hypothesized that personalized, sustained release formulation would enhance the pharmacotherapy by mimicking physiological concentration at higher level. Therefore, novel 24 h 3D printed (3DP) has been developed (M3DICORT) coupling hot-melt extrusion fused deposition modeling. A uniform drug distribution 3DP tablets demonstrated content 101.66 ± 1.60 % an acceptance value 4.01. had stable dissolution profile where intra-batch deviation was 2.8 and inter-batch 6.8 %. Tablet height were correlated (R2 = 0.996), providing tool easy dose personalization. Tablets maintained critical quality attributes, such as (f2 > 60) uniformity after process transfer from single-screw extruder to twin-screw extruder. Impurities observed final product which should be mitigated before clinical assessment. To our knowledge, M3DICORT first specifically AI.

Язык: Английский

Процитировано

21

Novel agents to treat adrenal insufficiency: findings of preclinical and early clinical trials DOI
Andrew Peel, R. Louise Rushworth, David J. Torpy

и другие.

Expert Opinion on Investigational Drugs, Год журнала: 2024, Номер 33(2), С. 115 - 126

Опубликована: Янв. 29, 2024

Adrenal insufficiency currently affects over 300/million population, with higher morbidity and mortality compared to the general population. Current glucocorticoid replacement therapy is limited by a lack of reliable biomarkers guide dosing, inter-patient variation in metabolism narrow therapeutic window. Increased may relate unappreciated under- or over-exposure glucocorticoids impaired cortisol circadian rhythm. New agents are required emulate physiological secretion individualize dosing.

Язык: Английский

Процитировано

5

Outcome of COVID-19 infections in patients with adrenal insufficiency and excess DOI Creative Commons
H. Nowotny, Jillian Bryce, Salma Ali

и другие.

Endocrine Connections, Год журнала: 2023, Номер 12(4)

Опубликована: Янв. 30, 2023

Background Information on clinical outcomes of coronavirus disease 19 (COVID-19) infection in patients with adrenal disorders is scarce. Methods A collaboration between the European Society Endocrinology (ESE) Rare Disease Committee and Reference Network Endocrine Conditions via Registries for allowed collection data 64 cases (57 insufficiency (AI), 7 Cushing’s syndrome) that had been reported by 12 centres 8 countries January 2020 December 2021. Results Of all patients, 23 were males 41 females (13 those children) a median age 37 51 years. In 45/57 (95%) AI cases, COVID-19 was confirmed testing. Primary present patients; affected Addison’s disease, congenital hyperplasia primary (PAI) due to other causes. The most relevant comorbidities hypertension (12%), obesity ( n = 14%) diabetes mellitus (9%). An increase 2.0 (IQR 1.4) times daily replacement dose 42 (74%) patients. Two administered i.m. injection 100 mg hydrocortisone, 11/64 admitted hospital. be transferred intensive care unit, one fatal outcome. Four persistent SARS-CoV-2 infection, others complete remission. Conclusion This multicentre questionnaire first collect outcome gland disorders. It suggests good case duly adjustments emphasizes importance patient education sick day rules.

Язык: Английский

Процитировано

11

Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy DOI Open Access
Aleksandra Basek, Grzegorz K. Jakubiak, Grzegorz Cieślar

и другие.

Cancers, Год журнала: 2023, Номер 15(24), С. 5786 - 5786

Опубликована: Дек. 10, 2023

Malignant neoplasms are currently one of the leading causes morbidity and mortality worldwide, posing a major public health challenge. However, recent advances in research cancer biology immunity have led to development immunotherapy, which is now used on an everyday basis treatment addition surgical treatment, classical cytostatics, radiotherapy. The efficacy immunotherapy has promoted great popularity this among patients, as well significant interest. increasing number patients being treated with not only reassures physicians technique but also shows wide spectrum side effects therapy, been considered before. Immune-related adverse events may affect many systems organs, such digestive, cardiovascular, respiratory, skin, or endocrine organs. Most complications mild moderate course, there life-threatening manifestations that essential be aware because if they properly diagnosed time, can fatal consequences. purpose paper was present results literature review current state knowledge (such adrenal crisis, thyroid storm, myxoedema diabetic ketoacidosis, severe hypocalcaemia) immune checkpoint inhibitors provide information symptoms, diagnostics, management strategies.

Язык: Английский

Процитировано

10

Frequency of stress dosing and adrenal crisis in paediatric and adult patients with congenital adrenal hyperplasia: a prospective study DOI Creative Commons

Lea Tschaidse,

Sophie Wimmer,

H. Nowotny

и другие.

European Journal of Endocrinology, Год журнала: 2024, Номер 190(4), С. 275 - 283

Опубликована: Март 30, 2024

Abstract Objective Patients with congenital adrenal hyperplasia (CAH) require life-long glucocorticoid replacement, including stress dosing (SD). This study prospectively assessed crisis (AC) incidence, frequency, and details of SD disease knowledge in adult paediatric patients their parents. Design Prospective, observational study. Methods Data on AC were collected via a patient diary. In case AC, medical records reviewed interviews conducted. Adherence to sick day rules the German Society Endocrinology (DGE) using version CAH assessment questionnaire (CAHKAQ) assessed. Results 187 patients, incidence was 8.4 per 100 years (py) 5.1 py 38 children. adults, 195.4 episodes recorded, children 169.7 py. 72.3% adults 34.8%, performed according recommendations. Children scored higher CAHKAQ than (18.0 [1.0] vs 16.0 [4.0]; P = .001). there positive correlation frequency (r .235, .011) score .233, .014), between .193, .026). Conclusion The are high. contrast cohort, majority not accordance DGE recommendations, underlining need for structured repeated education particular focus transition.

Язык: Английский

Процитировано

4

Adrenal crises in adolescents and young adults DOI Creative Commons
R. Louise Rushworth, Georgina L. Chrisp,

Suzannah Bownes

и другие.

Endocrine, Год журнала: 2022, Номер 77(1), С. 1 - 10

Опубликована: Май 18, 2022

Abstract Purpose Review the literature concerning adrenal insufficiency (AI) and crisis (AC) in adolescents young adults. Methods Searches of PubMed identifying relevant reports up to March 2022. Results AI is rare disorder that requires lifelong glucocorticoid replacement therapy associated with substantial morbidity occasional mortality among Aetiologies this age group are more commonly congenital, acquired causes, resulting from tumours hypothalamic-pituitary area autoimmune adrenalitis others, increasing age. All patients at risk AC, which have an estimated incidence 6 8 ACs/100 patient years. Prevention ACs includes use educational interventions achieve competency dose escalation parenteral administration during times physiological stress, such as intercurrent infection. While AI/AC children adults has been documented, there few studies focussed on AC occurrence AI. This despite range developmental, psychosocial, structural changes can interfere chronic disease management important period growth development. Conclusion In review, we examine current state knowledge epidemiology emerging adults; causes group; suggest areas for further investigation aimed reducing health impact these patients.

Язык: Английский

Процитировано

16

The role of hormones in ILC2‐driven allergic airway inflammation DOI Open Access

Zhong-Ling Dai,

Zhande Gong, Cui Wang

и другие.

Scandinavian Journal of Immunology, Год журнала: 2024, Номер 99(3)

Опубликована: Янв. 19, 2024

Group 2 innate lymphoid cells (ILC2s) are a type of immune that produce large amount IL-5 and IL-13 two cytokines crucial for various processes such as allergic airway inflammation, tissue repair homeostasis. It is known damaged epithelial-derived alarmins, IL-33, IL-25 thymic stromal lymphopoietin (TSLP), the predominant ILC2 activators mediate production cytokines. In recent years, abundant studies have found many factors can regulate development function. Hormones synthesized by body's endocrine glands or play an important role in response. Notably, ILC2s express hormone receptors their proliferation function be modulated multiple hormones during inflammation. Here, we summarize effects on ILC2-driven inflammation discuss underlying mechanisms potential therapeutic significance.

Язык: Английский

Процитировано

3

Adrenal insufficiency in severely wounded men with combat gunshot injury DOI Creative Commons
N. Yu. Seliukova, Катерина Місюра, Е.М. Khoroshun

и другие.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), Год журнала: 2025, Номер 20(8), С. 573 - 579

Опубликована: Янв. 4, 2025

War destroys normal life and is the main factor of human psychological physical vulnerability. The stress war most powerful pathogenic in emergence, detection exacerbation somatic, mental behavioral disorders. Trauma can affect functioning hypothalamus pituitary gland, as well hypothalamic-pituitary-adrenal axis. One these strong types gunshot injury and, consequently, surgical intervention resulting metabo­lic physiological disturbances. During stress, an excessive amount cortisol produced, but when body exhausted, level this hormone decreases, then adrenal insufficiency occurs. article considered secondary that develop a result after combat trauma with massive blood loss, which be objectively characterized acute male combatants. It important to pay attention recognition early prevention hypoglycemia insufficiency. So, continuous glucose monitoring should used. Although test quite safe, it desirable have simpler diagnostic marker obtained without administration adrenocorticotropic hormone. also recommended study serum, deficiency sex hormones. Measurement dehydroepiandrosterone sulfate included laboratory assessment hypothalamic-­pituitary-adrenal axis function. Dynamic measurements proven increase accuracy diagnosing Thus, cause non-specific symptoms person who has stress. Early testing based on clinical suspicion prevent further development crisis.

Язык: Английский

Процитировано

0